Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60,573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Zhu FC, et al. Among authors: li yh, li jx, li q. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20. Lancet. 2020. PMID: 32702299 Free PMC article. Clinical Trial.
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
Liang Y, Che Y, Yang B, Zhan F, Li H, Guan X, Zhang Y, Yin Q, Li C, Li J, Zhao Z, Liu L, Jiang G, Liao Y, Xu X, Ye J, Ren Q, He Y, Feng M, Wang L, Fan S, Cui X, Wang Z, Li C, Xiao H, Liu R, Li Q, Jiang C, Liu J, Li Q. Liang Y, et al. Among authors: li c, li j, li h, li q. J Infect Dis. 2019 Jan 1;219(1):50-58. doi: 10.1093/infdis/jiy469. J Infect Dis. 2019. PMID: 30085178 Clinical Trial.
Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial.
Shen H, Wang Z, Yang B, Cai K, Jiang C, Xie R, Xiao H, Ren Q, Qi Z, Li J, Li Q, Ye J, Zhan F. Shen H, et al. Among authors: li j, li q. Hum Vaccin Immunother. 2021 Feb 1;17(2):351-357. doi: 10.1080/21645515.2020.1778408. Epub 2020 Aug 12. Hum Vaccin Immunother. 2021. PMID: 32783769 Free PMC article. Clinical Trial.
Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.
Tong Y, Zhang X, Chen J, Chen W, Wang Z, Li Q, Duan K, Wei S, Yang B, Qian X, Li J, Hang L, Deng S, Li X, Guo C, Shen H, Liu Y, Deng P, Xie T, Li Q, Li L, Du H, Mao Q, Gao F, Lu W, Guan X, Huang J, Li X, Chen X. Tong Y, et al. Among authors: li j, li x, li l, li q. EClinicalMedicine. 2022 Jul 29;52:101596. doi: 10.1016/j.eclinm.2022.101596. eCollection 2022 Oct. EClinicalMedicine. 2022. PMID: 35923425 Free PMC article.
A shared N-terminal hydrophobic tail for the formation of nanoparticulates.
Zhang X, Wang K, Lin Q, Zheng M, Li Q, Li T, Hong Q, Zheng Q, Yu H, Gu Y, Li S, Xia N. Zhang X, et al. Among authors: li s, li t, li q. Nanomedicine (Lond). 2016 Sep;11(17):2289-303. doi: 10.2217/nnm-2016-0146. Epub 2016 Aug 8. Nanomedicine (Lond). 2016. PMID: 27499052
Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells.
Wang K, Zhou L, Chen T, Li Q, Li J, Liu L, Li Y, Sun J, Li T, Wang Y, Kong Z, Zheng Q, Zhang J, Yu H, Gu Y, Xia N, Li S. Wang K, et al. Among authors: li s, li t, li y, li j, li q. Microb Cell Fact. 2021 Dec 20;20(1):227. doi: 10.1186/s12934-021-01719-8. Microb Cell Fact. 2021. PMID: 34930257 Free PMC article.
Observation of Structures in the Processes e^{+}e^{-}→ωχ_{c1} and ωχ_{c2}.
Ablikim M, Achasov MN, Adlarson P, Ai XC, Aliberti R, Amoroso A, An MR, An Q, Bai Y, Bakina O, Balossino I, Ban Y, Bao HR, Batozskaya V, Begzsuren K, Berger N, Berlowski M, Bertani M, Bettoni D, Bianchi F, Bianco E, Bortone A, Boyko I, Briere RA, Brueggemann A, Cai H, Cai X, Calcaterra A, Cao GF, Cao N, Cetin SA, Chang JF, Chang TT, Chang WL, Che GR, Chelkov G, Chen C, Chen C, Chen G, Chen HS, Chen ML, Chen SJ, Chen SL, Chen SM, Chen T, Chen XR, Chen XT, Chen YB, Chen YQ, Chen ZJ, Cheng WS, Choi SK, Chu X, Cibinetto G, Coen SC, Cossio F, Cui JJ, Dai HL, Dai JP, Dbeyssi A, de Boer RE, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding B, Ding XX, Ding Y, Ding Y, Dong J, Dong LY, Dong MY, Dong X, Du MC, Du SX, Duan ZH, Egorov P, Fan YH, Fang J, Fang SS, Fang WX, Fang Y, Farinelli R, Fava L, Feldbauer F, Felici G, Feng CQ, Feng JH, Fischer K, Fritsch M, Fu CD, Fu JL, Fu YW, Gao H, Gao YN, Gao Y, Garbolino S, Garzia I, Ge PT, Ge ZW, Geng C, Gersabeck EM, Gilman A, Goetzen K, Gong L, Gong WX, Gradl W, Gramigna S, Greco M, Gu MH, Gu YT, Guan CY, Guan ZL, Guo AQ, Guo LB, Guo MJ, Guo RP, Guo YP, Guskov A, Han TT, Han WY, Hao XQ, Harris FA, He KK, He KL, Heinsius FHH,… See abstract for full author list ➔ Ablikim M, et al. Among authors: li qx. Phys Rev Lett. 2024 Apr 19;132(16):161901. doi: 10.1103/PhysRevLett.132.161901. Phys Rev Lett. 2024. PMID: 38701481
60,573 results
You have reached the last available page of results. Please see the User Guide for more information.